financetom
Business
financetom
/
Business
/
Adam Neumann moves to buy back WeWork as it seeks funds to exit bankruptcy, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Adam Neumann moves to buy back WeWork as it seeks funds to exit bankruptcy, FT reports
Apr 17, 2024 10:27 PM

(Reuters) - WeWork Inc ( WEWOQ ) founder Adam Neumann has made a fresh push to buy back the firm even as it seeks hundreds of millions of dollars to emerge from bankruptcy and avoid a sale, FT reported on Thursday.

The shared office space provider was running short of cash and needed as much as $400 million in fresh funding to have a chance of emerging viably, FT said, citing two people familiar with the matter.

Alex Spiro, an attorney for Neumann's real estate firm Flow told FT that the company and its financial partners were prepared to beat any other offer that WeWork ( WEWOQ ) has received by 10%.

Adam Neumann had submitted a bid of more than $500 million to buy back WeWork ( WEWOQ ), Reuters reported last month citing a person familiar with the matter.

WeWork ( WEWOQ ) did not immediately respond to a Reuters request for comment.

The SoftBank-backed company said earlier this month that it aims to emerge from Chapter 11 bankruptcy in the U.S. and Canada by May 31 and had negotiated more than $8 billion, or over 40%, reduction in rent commitments from landlords.

(Reporting by Devika Nair in Bengaluru; Editing by Rashmi Aich and Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
Sep 6, 2024
Sept 6 (Reuters) - Zenas BioPharma, which is developing immunology-based therapies, said on Friday it is targeting a valuation of as much as $689.7 million in its initial public offering in the United States. The company, backed by drugmaker Bristol-Myers Squibb ( BMY ) , is looking to raise as much as $211.7 million by offering 11.76 million shares priced...
Salesforce to buy data protection provider Own Company for $1.9 bln
Salesforce to buy data protection provider Own Company for $1.9 bln
Sep 6, 2024
Sept 5 (Reuters) - Salesforce ( CRM ) on Thursday said it has signed an agreement to buy Own Company, a provider of data protection and data management solutions, for $1.9 billion in cash. ...
BMO Comments on Unit Labor Costs and The
BMO Comments on Unit Labor Costs and The "Muddied" Message for Bank of Canada
Sep 6, 2024
06:47 AM EDT, 09/06/2024 (MT Newswires) -- The Bank of Canada (BoC) specifically pointed to still-solid wage gains relative to productivity as an inflation concern in its policy statement on Wednesday, noted Bank of Montreal (BMO). Solid wage growth isn't a pressure point if it is coincident with decent productivity growth. Sadly, Canada again saw an outright drop in output...
Sociedad Quimica y Minera de Chile Offering Senior Unsecured Notes Due 2034
Sociedad Quimica y Minera de Chile Offering Senior Unsecured Notes Due 2034
Sep 6, 2024
06:45 AM EDT, 09/06/2024 (MT Newswires) -- Sociedad Quimica y Minera de Chile ( SQM ) said in a regulatory filing Thursday it would issue and sell $850 million principal amount of its senior unsecured notes due 2034, carrying a 5.5% annual interest rate. The company anticipates closing the transaction around Tuesday, Sociedad added in its regulatory filing with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved